Results 141 to 150 of about 4,113 (206)

Comprehensive Analytical and Electrochemical Strategies for Glycoside Analysis and Detection: Running Head: Analytical Techniques for Detection of Glycosides. [PDF]

Chem Biodivers
Chopra A, Kumari Y, Kumar S, Sharma R, Sharma N, Singh AP, Kumar A, Bhatia R.   +7 more
europepmc   +1 more source

Update on clinical heart failure trials. [PDF]

Clin Res Cardiol
Hoevelmann J, Tokcan M, Kulenthiran S, Abdin A, Viljoen C, Böhm M.   +5 more
europepmc   +1 more source

Bidirectional ventricular tachycardia following ricin intoxication: a case report. [PDF]

Eur Heart J Case Rep
Steinacher A, Schratter A, Delle Karth G, Eisenburger P.   +3 more
europepmc   +1 more source

Nanoparticle-Based Targeted Drug Delivery Methods for Heart-Specific Distribution in Cardiovascular Therapy. [PDF]

Pharmaceutics
Tashima T.
europepmc   +1 more source

Heart failure evidence update 2026. [PDF]

Heart Fail Rev
Liori S, Kapelios CJ, Savarese G, Filippatos G.   +3 more
europepmc   +1 more source

The DIGIT-HF trial: Key amendments of study design. [PDF]

Eur J Heart Fail
Bavendiek U, Berliner D, Thomas NH, Liu X, Schwab J, Rieth A, Maier LS, Schallhorn S, Angelini E, Rathje F, Sandu MA, Geller W, Gaspar T, Hambrecht R, Zdravkovic M, Philipp S, Kosevic D, Nickenig G, Scheiber D, Winkler S, Becher PM, Lurz P, Hülsmann M, Schröder C, Seltmann A, von der Leyen H, Veltmann C, Störk S, Böhm M, Koch A, Bauersachs J.   +30 more
europepmc   +1 more source

Integrated multi-omics analysis identifies and validates endoplasmic reticulum stress and mitophagy-related biomarkers in MASLD. [PDF]

Sci Rep
Chen Q, Liu L, Feng J, Zhang C, Zhang Z.
europepmc   +1 more source

Cardiac Glycosides: From Natural Defense Molecules to Emerging Therapeutic Agents. [PDF]

Biomolecules
Ponce A, Flores-Maldonado C, Contreras RG.   +2 more
europepmc   +1 more source

Cardiac Glycoside 3β-Bufalin Suppresses Cancer Cell Proliferation by Coupling with Na⁺,K⁺-ATPase and Volume-Regulated Anion Channel Within Membrane Microdomains. [PDF]

Int J Mol Sci
Fujii T, Shimizu T, Shimizu Y, Katoh M, Okumura T, Fujii T, Sakai H.   +6 more
europepmc   +1 more source

CCT2 defines a highly cisplatin-resistant and poor-prognosis subtype of lung adenocarcinoma. [PDF]

Oncol Lett
Mao H, Su C, Han X, Wang G.
europepmc   +1 more source